Osocimab for VTE Prevention After TKA, Changes in FDA Approval and Regulation of Pharmaceuticals, Neuropsych Testing of Older Clinicians Prior to Recredentialing, and more
Jan 14, 2020
12:18
Episode Description
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the January 14, 2020 issue
Proudly Supported by
